InsidersTradesSigma
Follow the 舒泰神 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 舒泰神 has logged 2 insider filings. Market capitalisation: €11.3bn. The latest transaction was disclosed on 21 April 2022 (Sale). Among the most active insiders: 张洪山. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€1m
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,899 of 28,985 companies
34.1
score / 100
Value31
Quality38
FCF yld-1.8%
Earn yld-0.7%
EV/EBITDA·
ROE-11%
Gross mgn77%
Net mgn-35%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 April 2022
About 舒泰神
舒泰神 is a company focused on the health and pharmaceutical sector, dedicated to the development of innovative drugs. It is listed on the XSHE market.